| Sarah A Ellison Dietschi, APRN | |
|
183 Saint Paul St, Burlington, VT 05401-4636 | |
| (802) 863-6326 | |
| Not Available |
| Full Name | Sarah A Ellison Dietschi |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 183 Saint Paul St, Burlington, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255672820 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 1010092009 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah A Ellison Dietschi, APRN 22 Cumberland Rd, Burlington, VT 05408-2465 Ph: (415) 350-1542 | Sarah A Ellison Dietschi, APRN 183 Saint Paul St, Burlington, VT 05401-4636 Ph: (802) 863-6326 |
News Archive
Prime Healthcare Services has acquired the 151-bed Encino Campus of Encino-Tarzana Regional Medical Center from Tenet Healthcare Corporation ("Tenet") effective June 1 and will operate the hospital as Encino Hospital Medical Center.
Capstone Therapeutics announced today that participating subjects have reached the planned twelve-month timepoint in the first of its two ongoing AZX100 Phase 2a clinical trials in keloid scarring. Data analysis for these subjects is underway. Per protocol and the original clinical development plan, results of the two keloid scarring trials will be pooled for analytical purposes and are scheduled for release during 4Q2010.
Taro Pharmaceutical Industries Ltd. announced that it has been granted an Investigational New Drug ("IND") exemption by the United States Food and Drug Administration, ("FDA"), to permit clinical studies on T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid), one of a class of non-sedating barbiturate compounds currently in development by the Company.
Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for under-served medical needs in neurology and cardiology, announced the completion of the interim analysis of the pivotal efficacy study of olesoxime in the rare neurodegenerative condition Spinal Muscular Atrophy (SMA).
› Verified 5 days ago
Ms. Maureen Louise Dwyer, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Mcclure 5 Fletcherallen Healthcare, 111colchester Ave, Burlington, VT 05401 Phone: 802-847-2804 Fax: 802-847-2806 | |
Ms. Merja Cahoon, NNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-2370 | |
Brooke Hopkins Ryba, MSN, RN, WHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Patricia Manion, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 Flynn Ave, Burlington, VT 05401 Phone: 802-488-6200 Fax: 802-488-6919 | |
Erin Michelle Leighton, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1205 North Ave, Burlington, VT 05408 Phone: 802-863-1313 | |
Kayleigh Martincic, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 128 Lakeside Ave, Burlington, VT 05401 Phone: 802-657-7000 | |
Mrs. Susan Albertini White, NURSE PRACTITIONER Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-4589 |